Does USTEKINUMAB Cause Peripheral swelling? 2,230 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,230 reports of Peripheral swelling have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 2.6% of all adverse event reports for USTEKINUMAB.
2,230
Reports of Peripheral swelling with USTEKINUMAB
2.6%
of all USTEKINUMAB reports
1,096
Deaths
1,601
Hospitalizations
How Dangerous Is Peripheral swelling From USTEKINUMAB?
Of the 2,230 reports, 1,096 (49.1%) resulted in death, 1,601 (71.8%) required hospitalization, and 1,202 (53.9%) were considered life-threatening.
Is Peripheral swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 2,230 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Peripheral swelling?
ADALIMUMAB (13,837)
ETANERCEPT (12,654)
METHOTREXATE (10,632)
TOCILIZUMAB (8,030)
TOFACITINIB (7,830)
ABATACEPT (7,561)
LEFLUNOMIDE (7,254)
LENALIDOMIDE (6,364)
HYDROXYCHLOROQUINE (6,128)
RITUXIMAB (5,977)
Which USTEKINUMAB Alternatives Have Lower Peripheral swelling Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE